Highland Capital Management (Texas)’s ANI Pharmaceuticals ANIP Stock Holding History

Highland Capital Management (Texas)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$584K	Hold	7,100	–	–	0.04%	243
2019 Q1	$501K	Hold	7,100	–	–	0.03%	242
2018 Q4	$320K	Sell	7,100 -1,900	-21%	-$99.6K	0.02%	227
2018 Q3	$509K	Hold	9,000	–	–	0.03%	220
2018 Q2	$601K	Buy	9,000 +4,600	+105%	+$287K	0.04%	197
2018 Q1	$256K	Hold	4,400	–	–	0.01%	303
2017 Q4	$284K	Sell	4,400 -1,600	-27%	-$99.5K	0.02%	271
2017 Q3	$315K	Buy	6,000 +1,150	+24%	+$54.8K	0.02%	249
2017 Q2	$227K	Hold	4,850	–	–	0.01%	271
2017 Q1	$240K	Buy	+4,850	New	+$272K	0.01%	266

Other funds holding ANIP

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nomura Holdings

Nomura Holdings Tokyo, Japan $12B AUM 34.44% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First Manhattan

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return